| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |